MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 250mg capsules (Roche Prodcts Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 250mg capsules (Roche Prodcts Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 250mg capsules (Roche Prodcts Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 250mg capsules (Roche Prodcts Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 500mg tablets (Roche Products Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 500mg tablets (Roche Products Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 500mg tablets (Roche Products Ltd).

Stability Notes

Store in original package to protect from moisture.

Provenance

Compatibility information derived from CellCept 500mg tablets (Roche Products Ltd).

Stability Notes

Does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Celsentri 150mg tablets (ViiV Healthcare UK Ltd).

Stability Notes

Does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Celsentri 300mg tablets (ViiV Healthcare UK Ltd).

Stability Notes

Protect from light. Protect from moisture. Airtight container. Teratogenic.

Provenance

Compatiblity information derived from Myfortic 180mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.